Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America C-reactive Protein Testing Market, by Application
1.4.2 North America C-reactive Protein Testing Market, by Assay Type
1.4.3 North America C-reactive Protein Testing Market, by End User
1.4.4 North America C-reactive Protein Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. North America C-reactive Protein Testing Market by Application
4.1 North America Cardiovascular Disease Market by Country
4.2 North America Inflammatory Bowel Disease Market by Country
4.3 North America Rheumatoid Arthritis Market by Country
4.4 North America Diabetes Market by Country
4.5 North America Others Market by Country
Chapter 5. North America C-reactive Protein Testing Market by Assay Type
5.1 North America Immunoturbidimetric Assays Market by Country
5.2 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
5.3 North America Chemiluminescence Immunoassay (CLIA) Market by Country
5.4 North America Others Market by Country
Chapter 6. North America C-reactive Protein Testing Market by End User
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Diagnostic Laboratories Market by Country
6.3 North America Others Market by Country
Chapter 7. North America C-reactive Protein Testing Market by Country
7.1 US C-reactive Protein Testing Market
7.1.1 US C-reactive Protein Testing Market by Application
7.1.2 US C-reactive Protein Testing Market by Assay Type
7.1.3 US C-reactive Protein Testing Market by End User
7.2 Canada C-reactive Protein Testing Market
7.2.1 Canada C-reactive Protein Testing Market by Application
7.2.2 Canada C-reactive Protein Testing Market by Assay Type
7.2.3 Canada C-reactive Protein Testing Market by End User
7.3 Mexico C-reactive Protein Testing Market
7.3.1 Mexico C-reactive Protein Testing Market by Application
7.3.2 Mexico C-reactive Protein Testing Market by Assay Type
7.3.3 Mexico C-reactive Protein Testing Market by End User
7.4 Rest of North America C-reactive Protein Testing Market
7.4.1 Rest of North America C-reactive Protein Testing Market by Application
7.4.2 Rest of North America C-reactive Protein Testing Market by Assay Type
7.4.3 Rest of North America C-reactive Protein Testing Market by End User
Chapter 8. Company Profiles
8.1 Danaher Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Abbott Laboratories
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Horiba Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Randox Laboratories Limited
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Zoetis, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Quest Diagnostics Incorporated
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 SWOT Analysis
8.9 Laboratory Corporation of America Holdings
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 SWOT Analysis
8.10. Merck KGaA
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Unique Offerings 